BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 31075521)

  • 1. Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy.
    Qian X; Zhang J; Gu Z; Chen Y
    Biomaterials; 2019 Aug; 211():1-13. PubMed ID: 31075521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triggering Sequential Catalytic Fenton Reaction on 2D MXenes for Hyperthermia-Augmented Synergistic Nanocatalytic Cancer Therapy.
    Liang R; Li Y; Huo M; Lin H; Chen Y
    ACS Appl Mater Interfaces; 2019 Nov; 11(46):42917-42931. PubMed ID: 31635454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasmall Cu
    Hu R; Fang Y; Huo M; Yao H; Wang C; Chen Y; Wu R
    Biomaterials; 2019 Jun; 206():101-114. PubMed ID: 30927714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photonic/magnetic hyperthermia-synergistic nanocatalytic cancer therapy enabled by zero-valence iron nanocatalysts.
    Dai C; Wang C; Hu R; Lin H; Liu Z; Yu L; Chen Y; Zhang B
    Biomaterials; 2019 Oct; 219():119374. PubMed ID: 31369897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reactions.
    Tang Z; Liu Y; He M; Bu W
    Angew Chem Int Ed Engl; 2019 Jan; 58(4):946-956. PubMed ID: 30048028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocatalysts-Augmented and Photothermal-Enhanced Tumor-Specific Sequential Nanocatalytic Therapy in Both NIR-I and NIR-II Biowindows.
    Feng W; Han X; Wang R; Gao X; Hu P; Yue W; Chen Y; Shi J
    Adv Mater; 2019 Feb; 31(5):e1805919. PubMed ID: 30536723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular-vesicles delivered tumor-specific sequential nanocatalysts can be used for MRI-informed nanocatalytic Therapy of hepatocellular carcinoma.
    Wu H; Xing H; Wu MC; Shen F; Chen Y; Yang T
    Theranostics; 2021; 11(1):64-78. PubMed ID: 33391461
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in multifunctional nanomaterials for photothermal-enhanced Fenton-based chemodynamic tumor therapy.
    Manivasagan P; Joe A; Han HW; Thambi T; Selvaraj M; Chidambaram K; Kim J; Jang ES
    Mater Today Bio; 2022 Jan; 13():100197. PubMed ID: 35036895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomedicine Meets Fenton Chemistry.
    Tang Z; Zhao P; Wang H; Liu Y; Bu W
    Chem Rev; 2021 Feb; 121(4):1981-2019. PubMed ID: 33492935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Metal-Organic Framework (MOF) Fenton Nanoagent-Enabled Nanocatalytic Cancer Therapy in Synergy with Autophagy Inhibition.
    Yang B; Ding L; Yao H; Chen Y; Shi J
    Adv Mater; 2020 Mar; 32(12):e1907152. PubMed ID: 32053261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic nanocatalysts as multifunctional platforms in cancer therapy through the synthesis of anticancer drugs and facilitated Fenton reaction.
    Khan S; Sharifi M; Hasan A; Attar F; Edis Z; Bai Q; Derakhshankhah H; Falahati M
    J Adv Res; 2021 May; 30():171-184. PubMed ID: 34026294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulating Intratumoral Fenton Chemistry for Enhanced Chemodynamic and Chemodynamic-Synergized Multimodal Therapy.
    Zhou Y; Fan S; Feng L; Huang X; Chen X
    Adv Mater; 2021 Dec; 33(48):e2104223. PubMed ID: 34580933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boosting Reactive Oxygen Species Generation with a Dual-Catalytic Nanomedicine for Enhanced Tumor Nanocatalytic Therapy.
    Su G; Xu H; Zhou F; Gong X; Tan S; He Y
    ACS Appl Mater Interfaces; 2023 Dec; 15(51):59175-59188. PubMed ID: 38095444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron-Based Theranostic Nanoplatform for Improving Chemodynamic Therapy of Cancer.
    Liu X; Jin Y; Liu T; Yang S; Zhou M; Wang W; Yu H
    ACS Biomater Sci Eng; 2020 Sep; 6(9):4834-4845. PubMed ID: 33455215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocatalytic Tumor Therapy by Single-Atom Catalysts.
    Huo M; Wang L; Wang Y; Chen Y; Shi J
    ACS Nano; 2019 Feb; 13(2):2643-2653. PubMed ID: 30753056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing inorganic nanomaterials for chemodynamic cancer therapy.
    Mohammed DF; Madlool HA; Faris M; Shalan BH; Hasan HH; Azeez NF; Abbas FH
    Nanomedicine (Lond); 2022 Oct; 17(24):1891-1906. PubMed ID: 36647807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-Fenton Reactors as a New Class of Oxidative Stress Amplifying Anticancer Therapeutic Agents.
    Kwon B; Han E; Yang W; Cho W; Yoo W; Hwang J; Kwon BM; Lee D
    ACS Appl Mater Interfaces; 2016 Mar; 8(9):5887-97. PubMed ID: 26888039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocatalytic Medicine.
    Yang B; Chen Y; Shi J
    Adv Mater; 2019 Sep; 31(39):e1901778. PubMed ID: 31328844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Progress on Improving the Efficiency of CDT by Exacerbating Tumor Acidification.
    Chen W; Liu J; Zheng C; Bai Q; Gao Q; Zhang Y; Dong K; Lu T
    Int J Nanomedicine; 2022; 17():2611-2628. PubMed ID: 35712639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocatalytic Tumor Therapy by Biomimetic Dual Inorganic Nanozyme-Catalyzed Cascade Reaction.
    Gao S; Lin H; Zhang H; Yao H; Chen Y; Shi J
    Adv Sci (Weinh); 2019 Feb; 6(3):1801733. PubMed ID: 31168441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.